Condition

Schizophreniform Disorder

ClinicalTrials.gov condition label

Clinical trials75

Recruiting4

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Cognitive Strategies in Early Psychosis 2NCT07263022 · 2026-07-17

MicroRNAs as Biomarkers in First Episode SchizophreniaNCT07703670 · 2026-07-01

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisNCT07645443 · 2026-05-27

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia EpisodeNCT05890183 · 2023-05-23

Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaNCT07715253 · 2026-12-01

NOT_YET_RECRUITING

Minocycline Augmentation of Clozapine for Treatment Resistant SchizophreniaNCT02533232 · 2022-08-30

The Effects of Kynurenine Aminotransferase Inhibition in People With SchizophreniaNCT04013555 · 2020-01-20

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia EpisodeNCT04203056 · 2019-12-16

Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance LifeNCT03757988 · 2018-12-06

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831NCT03201757 · 2017-06-15

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia EpisodeNCT02823041 · 2016-10-13

Clonazepam Effects on Brain Oscillations and Cognition in SchizophreniaNCT03061136 · 2016-10-01

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderNCT03043820 · 2016-08-01

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)NCT02160249 · 2015-09-01

Electronic Cigarettes in Smokers With Mental IllnessNCT02212041 · 2014-09-24

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisNCT02566057 · 2014-07-10

Prednisolone Addition for Patients With Recent-onset Psychotic DisorderNCT02949232 · 2014-07-01

Integrated Metacognitive Therapy in First Episode PsychosisNCT02131116 · 2014-05-01

rTMS in First Episode PsychosisNCT02131129 · 2014-04-30

Association of Amisulpride Response in Schizophrenia With Brain ImageNCT02095938 · 2014-01-01

Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With SchizophreniaNCT02787122 · 2014-01-01

RCT of Methotrexate Added to Treatment As Usual in SchizophreniaNCT02074319 · 2013-12-01

Enhancing Cognitive Training Through Exercise After a First Schizophrenia EpisodeNCT02267070 · 2013-11-01

Simvastatin Addition for Patients With Recent-onset SchizophreniaNCT01999309 · 2013-10-01

Effectiveness of Adherence Therapy for SchizophreniaNCT01780116 · 2013-05-01

Naltrexone for Antipsychotic-Induced Weight GainNCT01866098 · 2013-05-01

Omega-3 Dietary Supplements in SchizophreniaNCT01786239 · 2013-05-01

Antipsychotic Effects on Brain Function in SchizophreniaNCT01913327 · 2013-04-01

Contrasting Group Therapy Methods for PsychosisNCT01764568 · 2013-01-01

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsNCT01731119 · 2012-12-01

Lifestyle Intervention for Diabetes and Weight Management in PsychosisNCT01828931 · 2012-12-01

Biomarkers in First Episode SchizophreniaNCT02033382 · 2012-07-01

Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaNCT02137993 · 2012-03-01

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?NCT01481883 · 2012-01-01

Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagenNCT01555814 · 2011-05-01

Optimization of Treatment and Management of Schizophrenia in EuropeNCT01248195 · 2011-05-01

Brain Circuits in Schizophrenia and SmokingNCT01425684 · 2010-12-20

Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease StatesNCT01425671 · 2010-11-30

Multi-disciplinary Treatment for Patients Experiencing First Episode of PsychosisNCT01216891 · 2010-10-01

Randomized Double Blind Placebo Control Study in Patients with SchizophreniaNCT01602029 · 2010-08-01

An Integrated Program for the Treatment of First Episode of PsychosisNCT01321177 · 2010-07-01

Prevention of Weight Gain in Early PsychosesNCT01075295 · 2010-02-01

DECIFER: Depression and Citalopram In First Episode RecoveryNCT01041274 · 2010-01-01

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of SchizophreniaNCT01029769 · 2009-12-01

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.NCT00716755 · 2009-10-01

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyNCT01269710 · 2009-10-01

Role of Anti-Inflammatory Agents in Patients With SchizophreniaNCT00929955 · 2009-06-01

Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset SchizophreniaNCT00847600 · 2009-03-01

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With SchizophreniaNCT00825045 · 2008-12-01

Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral TherapyNCT00791440 · 2008-11-01

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsNCT00734435 · 2008-09-01

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight GainNCT00709202 · 2008-07-01

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With SchizophreniaNCT00749970 · 2008-07-01

Schizophrenic Patients in Integrated CareNCT00681629 · 2008-07-01

A German Multicenter Study on Toxoplasma Gondii in First-episode SchizophreniaNCT00686400 · 2008-05-01

An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersNCT01855074 · 2007-11-01

Anticholinergic Burden in SchizophreniaNCT00715377 · 2007-06-01

Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisNCT00465920 · 2007-05-01

Integrated Care in Psychotic Disorders With Severe Mental IllnessNCT01888627 · 2007-05-01

Donepezil Double Blind Trial for ECT Memory DisfunctionNCT00465283 · 2007-05-01

Common interventions

Leading sponsors

Centre for Addiction and Mental Health5 University of Maryland, Baltimore5 University of North Carolina, Chapel Hill5 Northwell Health4 Pakistan Institute of Living and Learning4 University of California, Los Angeles4 New York State Psychiatric Institute3 The Alfred3 AstraZeneca2 Indiana University2 Iris Sommer2 Janssen-Cilag, S.A.2 NYU Langone Health2 Alkermes, Inc.1 Bayside Health1

Trial status mix

COMPLETED53

TERMINATED9

UNKNOWN7

RECRUITING4

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

NA28

PHASE419

PHASE29

PHASE17

PHASE35

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.